Introduction
============

The quantitative study of gene expression in terms of the amount of RNA produced by a certain gene in a given biological condition is fundamental to our understanding of gene structure and function. Molecular laboratory techniques used to quantitatively measure RNA expression levels include northern blot analysis, reverse transcription-polymerase chain reaction (RT-PCR), expression microarrays and, recently, RNA sequencing (RNA-Seq). These techniques typically require a form of normalization of the measured RNA expression level of a gene to account for the potentially different RNA input quantities used in the assay. The best way to do this is to relate the transcripts to the number of templates (DNA strands) creating them. Owing to difficulties in obtaining these parameters from the same samples, several methods have been proposed over the years and are commonly used to relate the RNA amount of a given molecular species to one or more reference RNAs that are assumed to be expressed at a constant level in the cell type under consideration ([@b1-mmr-16-03-2397]). More specifically, the ideal reference (or control) gene for the study of gene expression in a given organism should: i) Be expressed at a medium-high level so it can be easily detected; ii) be expressed at a constant/stable level in different cell types and within the same cell type undergoing different treatments; and iii) maintain these features through as many different tissues as possible within the organism (that is, ubiquitously expressed). These features would maximize the usefulness of the genes in the expression studies ([@b2-mmr-16-03-2397]).

From a biological point of view, the theoretical requirements for an ideal reference gene appear to be best suited to the housekeeping (HK) genes, a large class of genes that are constitutively expressed, subjected to low levels of regulation in different conditions and perform biological actions that are fundamental for the basic functions of the cell ([@b1-mmr-16-03-2397]). Their fundamental roles also mean that they tend to be expressed in high levels, confirming their suitability as reference genes.

Since the 1980s, several human genes have been widely used as 'classic' reference genes based on their fulfilling of the aforementioned requirements, as assessed typically by northern blot analysis ([@b3-mmr-16-03-2397]), and this set of genes was seamlessly transferred for use in RT-PCR analyses in the 1990s ([@b4-mmr-16-03-2397]). However, in a situation in which there was only preliminary knowledge of the human genome, the choice of these genes could be only anecdotal, among the limited pool of the genes known at the time. Following the widespread use of expression microarray techniques in the early 2000s ([@b5-mmr-16-03-2397]), along with the initial sequencing and characterization of the human genome, it became theoretically possible to study and select HK genes by the systematic analysis of transcriptomes. This possibility was readily exploited in certain initial studies ([@b6-mmr-16-03-2397],[@b7-mmr-16-03-2397]), which demonstrated that common control genes used in human studies, including the most popular glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*), actin β (*ACTB*) and β~2~-microglobulin (*B2M*) ([@b3-mmr-16-03-2397],[@b8-mmr-16-03-2397],[@b9-mmr-16-03-2397]), actually exhibited considerable variability in expression within and across microarray data sets, and in certain cases this was confirmed by quantitative RT-PCR (RT-qPCR) analysis ([@b10-mmr-16-03-2397]). The main conclusion was that the choice of a reference gene should be suited to the specific investigated tissue. In the following years, the problem of selecting a human HK gene by exploiting the availability of transcriptome-scale data was addressed by several studies and remains under debate ([@b11-mmr-16-03-2397]).

The present study considered whether recent advancements in the quality and completeness of human expression microarray data, along with developments in statistical analysis, may be able to provide new clues toward the quantitative standardization of human tissue gene expression studies, cross- and within-tissue. A general framework is presented for choosing reference genes that may be useful in gene expression studies on normal human tissues and organs; the present study also addresses certain previous assumptions and provides an approach that is based on the Transcriptome Mapper (TRAM; <http://apollo11.isto.unibo.it/software/TRAM>) tool, which can overcome a number of problems associated with cross-platform analysis (such as, probe assignment to locus, intra- and inter-sample normalization and scaled quantile statistics) ([@b12-mmr-16-03-2397],[@b13-mmr-16-03-2397]). TRAM can integrate data from hundreds or thousands of complete microarray data sets and provide unique combinations of features that are particularly suited to allow the choice of reference genes based on the three properties aforementioned. TRAM calculates a quantitative measurement for a consensus mean-expression value for tens of thousands of human transcripts expressed in a specific tissue or organ, thus allowing for a precise estimation of the intensity of its expression in terms of a percentage of the mean expression value in the pool of analyzed transcriptomes and the choice of a reference gene expressed at medium-high or high level ([@b12-mmr-16-03-2397],[@b14-mmr-16-03-2397]). In addition, TRAM provides the standard deviation (SD) from the mean (normalized as the percentage of the mean value) for the mean expression value of a given locus, thus allowing for the selection of genes that may have more stable expression values in a variety of different samples and/or experimental platforms that have been investigated for a given tissue/organ. Finally, TRAM is able to integrate data from numerous sources, allowing verification of the consistency of the first two features through a wide range of different tissues within the organism studied ([@b12-mmr-16-03-2397]).

The present study conducted a meta-analysis of 646 data sets that were obtained from different studies associated with 54 different normal human tissues and organs, using various experimental platforms. This meta-analysis produced results for 35,131 individual loci, including known genes and expressed sequence tag (EST) clusters, in the form of a database that may be extensively queried by freely combining a number of criteria, thus identifying the best intersection of moderate-high level of expression, low expression-value variability and expression in a large number of tissues. Results from the present study demonstrated that the human actin γ 1 (*ACTG1*) gene may potentially be used as a general reference gene for human cross-tissue studies and that specific genes are most suited for individual within-tissue studies. An enrichment analysis in functional classes for the identified HK genes is also presented.

Materials and methods
=====================

### Database search

To retrieve data sets that have been derived from normal adult human tissues, a systematic search of the gene expression data repository Gene Expression Omnibus (GEO; <https://www.ncbi.nlm.nih.gov/geo>) ([@b15-mmr-16-03-2397]) was performed for any available sample series associated with pools of normal human tissues/organs, choosing *Homo sapiens* as the organism. The query used was: 'Homo sapiens \[ORGANISM\] AND tissue\* \[TI\] OR organ\* \[TI\]'. These selection criteria led to the generation of a pool of samples that included all of the main human organs and tissues, which served as a reference set already partially used by the authors of the present study ([@b14-mmr-16-03-2397]). The searches were performed up to May 2013, and search results were then filtered using inclusion and exclusion criteria as explained in the *Data set selection* subsection below.

### Data set selection

Inclusion criteria of data sets used in the present analysis were: i) Experiments were carried out on whole organs or tissues; ii) organs/tissues were obtained from individuals exhibiting normal phenotypes; iii) samples used in the studies were obtained from adults; and iv) the availability of the raw or pre-processed data. Exclusion criteria included: i) Studies using exon arrays (which hamper data elaboration by TRAM, owing to an exceedingly high number of data rows) or platforms using probes that are split into several different arrays for each sample, which hampers intra-sample normalization; ii) platforms that examine an atypical number of genes (that is, \<5,000 or \>60,000); and iii) data that is derived from cell lines, pathological or treated tissue, or children or fetal tissues.

A quantitative transcriptome map was obtained by linearizing values from each data set that were provided as logarithms. If only raw files (such as CEL files) were available in the GEO database, they were converted into pre-processed data using the AltAnalyze version 2.0 program (<http://www.altanalyze.org>) ([@b16-mmr-16-03-2397]). [Tables I](#tI-mmr-16-03-2397){ref-type="table"} and [II](#tII-mmr-16-03-2397){ref-type="table"} summarize the data sets used to build the integrated transcriptome map from different human tissues/organs. The mean number of retrieved data sets was 22.2±6.6 for the group of the main tissues/organs ([Table I](#tI-mmr-16-03-2397){ref-type="table"}) and 6.5±5.2 for the group of the minor tissues/organs ([Table II](#tII-mmr-16-03-2397){ref-type="table"}) since there were a lower number of representatives of certain of them owing to the limited availability of data in the repositories.

### TRAM analysis

The TRAM tool ([@b12-mmr-16-03-2397]) allows gene expression data to be imported in a tab-delimited text format. It also allows data integration by decoding probe-set identifiers to gene symbols using UniGene data parsing ([@b17-mmr-16-03-2397]), normalizing data from multiple platforms using intra-sample and inter-sample normalization (that is, scaled quantile normalization) ([@b13-mmr-16-03-2397]), and creates tables of expression values for each transcript.

A directory (folder) was created that contains the whole pool of all the sample data sets (n=646) associated with 54 different human tissues/organs that were retrieved and downloaded from the GEO database. This set included 629 samples described previously ([@b14-mmr-16-03-2397]), which were in addition to the following GEO samples: GSM2829, GSM2856, GSM18792, GSM18793, GSM18951, GSM18952, GSM39975, GSM39980, GSM39992, GSM39994, GSM39999, GSM40001, GSM44671, GSM52565, GSM175935, GSM790822 and GSM790831. These samples were pre-processed according to the TRAM tool guide to be ready for import and processing in TRAM. During the pre-processing step, TRAM allows the linearization of data sets when provided as logarithms. All pre-processed samples of the whole pool were then imported as pool B in the TRAM table, and the entire set of analyses permitted by TRAM was performed as described in detail in the tool guide, using default parameters as previously described ([@b12-mmr-16-03-2397]). The significance of the over-/underexpression of single genes was determined within pool B by running TRAM in 'Map' mode ([@b12-mmr-16-03-2397]) with a segment window of 12,500 bp and a minimum number of one over-/underexpressed gene in that window. This window size is \<20% of the 67 kb mean size of a human protein-coding gene, as determined by searching the GeneBase database ([@b18-mmr-16-03-2397]); therefore, significant over-/underexpression of a segment \[at q\<0.05, where q is the P-value corrected for false discovery rate ([@b12-mmr-16-03-2397])\] almost always corresponds to that of a single gene. When the segment window contains \>1 gene, significance is maintained if the expression value of the over-/underexpressed gene prevails over the others.

To study tissues or organs individually, 10 representative biological conditions were selected ([Table I](#tI-mmr-16-03-2397){ref-type="table"}) and the data were exported for the pool of samples relative to each tissue/organ from the TRAM table 'Values B' and reimported in TRAM as pool A to allow comparison between the specific tissue/organ (pool A) and the whole pool (pool B).

TRAM version 1.2.1, 2015 human version, was used in the present study and is freely available at <http://apollo11.isto.unibo.it/software>. The complete set of TRAM results from the import and analysis of the 646 data sets is not currently distributed owing to its very large size (25 GB); only the final results are available. However, the complete set of results may be regenerated locally by running the automated import and analysis of the data sets in the aforementioned pool B folder into the TRAM 1.2.1 software. Briefly, gene expression values were assigned to individual loci using UniGene, data were subjected to intra-sample normalization as a percentage of the mean value and then to inter-sample normalization by scaled quantile. The value for each locus within each biological condition is the mean of all available values for that locus. The median value of whole genome gene expression was used to determine the percentiles of expression for each gene. Only mapped genes or EST clusters with an assigned gene name or UniGene code, respectively, that have start and end genomic coordinates, and have a non-empty raw intensity value were selected for the analysis.

Further improvements were made for the present study by adding the total number of biological samples (microarrays) from which each gene expression value is derived, in addition to the number of data points, as certain experimental platforms used to assess expression levels for a sample may contain a variable number of microarray spots, each with a different probe, which generate multiple expression data points for the same gene. These improvements are available (upon request) as a dedicated script and are to be fully integrated into the next version of TRAM (TRAM 1.3), which is due to be released in 2017. Since a different number of microarray spots may be available on a platform for a given gene, these new features offer the possibility to normalize the quantity of information that is available for a gene based on the actual number of distinct biological samples that provide measured expression values for that gene.

To create transcriptome maps, TRAM does not consider probes for which expression values are not available, assuming that an expression level has not been measured. Furthermore, the software gives 95% of the minimum positive value present in a sample to those expression values ≤0 to obtain meaningful numbers when it is required to obtain a ratio between values in pool A and pool B. If it is assumed that, in these cases, the expression level is too low to be detected under the experimental conditions used, then this transformation may be useful to highlight differential gene expression.

### HK gene search

The predicted genes that behave as HK genes were determined, as they are mainly involved in fundamental cellular functions and are ubiquitously and constitutively expressed in all tissues ([@b19-mmr-16-03-2397]--[@b21-mmr-16-03-2397]). A search for HK genes in the transcriptome maps was performed using the following parameters: i) An expression value ≥300, which in TRAM is given as a percentage of the mean expression value in a sample in order to select genes that are expressed at least threefold above the mean value and are therefore expressed at an easily appreciable level; ii) a SD ≤30, expressed as a percentage of the mean value to identify genes with a low expression variation among different samples; and iii) a sample number ≥80% of the total number of samples for each analyzed pool to select commonly expressed HK genes (for example, ≥80% indicates 16 out of 20 samples for adipose tissue). When a very low number of suitable HK genes were identified by these criteria, the parameters were relaxed to ≥150 mean expression value, ≤45% SD and ≥65% of samples in the pool with a measured value for the gene ([Table I](#tI-mmr-16-03-2397){ref-type="table"}).

To select the HK genes with the best overall features to be proposed as reference genes, the genes identified as fitting the described criteria were first arranged in descending order of expression value, followed by ascending order of SD% and finally by descending order of sample number. An ascending rank number was assigned for each sorting criterion, the mean among these three ranks was calculated and the lowest mean rank was considered to correspond to the gene with the overall best fit to the three criteria. For tissue-specific analysis, a fourth criterion was added by calculating the ascending rank of the absolute deviation from 1 of the ratio between the mean expression value of the gene in the considered tissue and in the whole pool of 646 samples, respectively (lowest rank considered the best). This fourth criterion selected for genes with the most similar expression values in the whole pool and each tissue-specific pool, suggesting a particularly stable expression level. The mean rank was then calculated for all four criteria.

### Functional analysis

The hypothesis that the most suitable HK genes identified in the analysis could be enriched for particular functional classes was tested using the web tool FuncAssociate version 3.0 (<http://llama.mshri.on.ca/funcassociate>) ([@b22-mmr-16-03-2397]).

Results
=======

### Human HK genes for general use

Using the search criteria detailed in the Methods section of the present study, several genes that were present in ≥65% of the whole pool list of 646 samples from 54 human tissues/organs were identified. A total of eight genes were identified that best fulfilled the criteria to be proposed as reference genes ([Table III](#tIII-mmr-16-03-2397){ref-type="table"}), and the HK gene that best fit the combination of all the traditional criteria to be used as a general reference gene was *ACTG1*.

### Human HK genes for individual tissues

A total of 10 human tissues/organs were selected for a systematic search for the best suitable references genes within the respective biological type. By searching with the four criteria aforementioned, several genes were identified that had a mean expression value ≥300 (or ≥150, for searches performed with less stringent criteria), with an SD≤30 (or SD≤45) and with an expression value measured in ≥80% (or ≥65% with relaxed criteria) of the samples within different tissues/organs ([Tables IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}). The eight known genes with the lowest mean rank scored for the selected criteria are listed in [Table IV](#tIV-mmr-16-03-2397){ref-type="table"} (adipose tissue and bone marrow), [Table V](#tV-mmr-16-03-2397){ref-type="table"} (brain, heart and skeletal muscle), [Table VI](#tVI-mmr-16-03-2397){ref-type="table"} (kidney, liver and lung) and [Table VII](#tVII-mmr-16-03-2397){ref-type="table"} (ovary and testis). The complete gene name corresponding to each gene symbol listed in [Tables III](#tIII-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"} is provided in [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"}, along with the number of times that each gene is represented in a different pool among the 11 pools analyzed in [Tables III](#tIII-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}.

### Analysis of the associated function

Using the FuncAssociate web tool, the identified HK genes were revealed to be significantly enriched in certain functional classes. Of the genes identified as suitable for human tissue-wide use listed in [Table III](#tIII-mmr-16-03-2397){ref-type="table"}, there were statistically significant enrichments \[with adjusted P-value (P-adj)≤0.05\] only in the Gene Ontology categories: Ribosome (P-adj=0.003), translation termination (P-adj=0.038), translation elongation (P-adj=0.045) and cellular protein complex disassembly (P-adj=0.05).

A significant enrichment in numerous Gene Ontology categories was also identified by pooling in a unique list all 63 genes ([Table IX](#tIX-mmr-16-03-2397){ref-type="table"}) identified for the 10 specific tissues/organs ([Table IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}); all enrichments were associated with basic cellular components, molecular functions and/or biological processes. The biological process with the highest statistical significance (P-adj\<0.001) was RNA catabolic processes and translation (data not shown).

Discussion
==========

Following the diffusion of expression microarray technology, a number of attempts have been made to use microarray data to perform a systematic analysis of the features of gene expression to identify HK genes that may be best suited as reference genes. Early attempts suffered from the limited number of samples available for analysis in addition to a lack of choice of computational biology techniques to analyze them, in particular for cross-platform analysis ([@b6-mmr-16-03-2397]). Similar investigations were also conducted using the EST database ([@b23-mmr-16-03-2397]) and, in recent years, RNA-Seq data ([@b24-mmr-16-03-2397],[@b25-mmr-16-03-2397]). However, the generation of ESTs is subject to certain biases depending on the level of ability for an mRNA to be cloned during the generation of the cDNA EST libraries; therefore, although these data are useful to identify expressed sequences, they are less useful for quantitative analysis. RNA microarrays and RNA-Seq are the two main types of high-throughput technologies used to assess gene expression ([@b26-mmr-16-03-2397]). Although RNA-Seq is considered to be more sensitive and has a broader dynamic range than RNA microarrays ([@b27-mmr-16-03-2397]), in large comparative studies these two methods have produced comparable results in terms of gene expression profiling ([@b27-mmr-16-03-2397]--[@b29-mmr-16-03-2397]). Microarrays remain an accurate tool for measuring the levels of gene expression ([@b29-mmr-16-03-2397]) and continue to provide useful data-mining resources. The approach of the present study takes advantage of the large number of previous transcriptomic studies that were performed with microarray technology and stored in publicly available databases, and also of the results provided in the form of a list of genes and the corresponding expression values.

The diverse origin of the data, in terms of different investigated individuals, different experimenters and different experimental platforms in the field of microarray analysis, provided a richness in the context of an analysis such as in the present study. That is, following data integration, the final results were not affected by systematic biases that may be linked to the particular samples or experimenters/platforms involved in the generation of the data, and they are likely to best represent the actual 'mean' status for a gene ([@b12-mmr-16-03-2397]), compared with works based only on the original data obtained through a single platform ([@b6-mmr-16-03-2397]). In addition, the approach of the present study exploited the combination of: i) Automated reassignment of probes to the corresponding genes by the updated UniGene data embedded in TRAM; ii) intra- and inter-sample normalization, including the scaled-quantile method that allows for comparison among platforms with a highly different number of probes; and iii) elaboration and representation of gene expression values in linear form within an indexed, searchable database, with a graphical interface recording quantitative levels of expression (mean expression values), expression variability (SD) and cross-tissue expression of more than 31,000 transcripts. These features represent a clear advancement in comparison with other meta-analyses that were based on published microarray data and were also aimed at identifying human reference genes ([@b30-mmr-16-03-2397],[@b31-mmr-16-03-2397]), particularly considering that several studies on the subject were conducted in years when there was a reduced availability of samples and/or the experimental platforms were less complete ([@b32-mmr-16-03-2397]).

The meta-analysis in the present study was performed on a pool of 646 data sets from 54 different human whole tissues/organs, and excluded analyses of individual cell types as the whole organ/tissue includes a vast number of cell types in its structure \[as discussed by Fagerberg *et al* ([@b33-mmr-16-03-2397])\], and also due to the requirement of selecting a representative set of samples as a result of the very long elaboration time for each analysis. The *ACTG1* gene was identified as the HK gene that best fit the selection criteria for use as a general reference gene in the study of human gene expression. This gene proved to be statistically significantly over-expressed in the transcriptome map, according to the described criteria ([@b34-mmr-16-03-2397]), with the following features: A very high mean expression value (3,453.7, indicating an expression level of \~35-fold in comparison with the mean expression value of all the genes in each sample, set as equal to 100) and an SD% of 37.8%; the number of samples in which a measure for this gene was available was 513 out of 646 (79.4%). Notably, this well-characterized gene, whose coding sequence appears to be completely characterized ([@b35-mmr-16-03-2397]), encodes for a cytoplasmic form of actin that is known to be ubiquitously expressed in human cells, but is different from the actin β (*ACTB*) that is routinely used as a reference gene. According to the data of the present study, the commonly used reference genes *ACTB* and *GAPDH* had excellent features in terms of high expression value and diffuse expression in human cells. However, they have an SD% almost double that of *ACTG1*. Owing to the high similarity between *ACTB* and *ACTG1* (91% identity with no gaps between their coding sequences, as determined by standard BLASTN analysis; data not shown), probes and primers need to be accurately selected to specifically identify the desired form of RNA.

Among the HK genes identified to be best suited as general reference genes for human studies, two ribosomal protein genes, *RPS18* and *RPS27*, and one aquaporin gene, POM121 transmembrane nucleporin C (*POM121C*), were identified. *ACTG1* and *RPS27* were also included in the top 20 HK human genes across 42 human tissues in a previous study based on a single platform ([@b36-mmr-16-03-2397]), however, the data sets from the present study were not included in the present meta-analysis since it was not possible to derive the expression values as linear numbers for each microarray channel from the deposited data. Notably, the eight genes listed in [Table III](#tIII-mmr-16-03-2397){ref-type="table"} were also classified at the transcript and protein level as 'expressed in all tissues' in the Human Protein Atlas ([@b33-mmr-16-03-2397]), further supporting the results of the present study regarding them as the most generally suitable reference genes.

In accordance with the relevance of the *ACTG1* gene in cross-tissue analysis, this gene is also present in the greatest number of lists (n=5) of the 10 tissue-specific genes best fulfilling criteria to be used as reference genes ([Tables IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}). Ribosomal proteins were another notable example of known classes of general HK genes that are well represented in several human tissues. Although there is a clear, expected prevalence among the identified loci of genes encoding for basic cell structure (such as genes encoding for cytoskeletal components) and function (such as genes encoding for transcription and translation, reduction-oxidation metabolism and signaling proteins), it is worth noting that specific members of the same gene family involved in these processes may be identified in one particular tissue/organ and not in the others. The vast majority of genes that may be more suitable as reference genes for individual tissues ([Tables IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}) are still typical HK genes, with the clear exception of the tissue-specific myoglobin gene in the heart ([Table V](#tV-mmr-16-03-2397){ref-type="table"}).

The approach used in the present study allows for the systematic search for ideal reference genes and, at the same time, made available a 'consensus' reference gene-expression profile for 10 human tissues/organs. From this particular point of view, the presented results are less systematic than other previous attempts conducted in the case of the brain ([@b34-mmr-16-03-2397]) and heart ([@b14-mmr-16-03-2397]). Only the samples belonging to experiments in which a series of normal human tissues were analyzed have been included here, without searching for any single samples recorded for a given tissue in any type of available experiment (for example, comparisons between normal and pathological samples). However, the present data have been obtained through an improvement of the search algorithm for HK genes and may still offer interesting hints to their biological specificity in the transcriptome of these tissues. The same approach may be applied to data sets deriving from cell lines or pathological samples.

Systematic analysis aimed to evaluate if the genes identified as possible reference genes ([Tables IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}) were significantly enriched in a particular class of genes confirmed to be involved in the most basic biological processes; in particular, in the metabolism of the informational macromolecules (nucleic acids and proteins). This therefore justifies their tendency to constitutive, stable and almost universal expression, which was also observed in a previous analysis that ranked genes by combining the average expression level and its SD in a single score ([@b37-mmr-16-03-2397]). The biological peculiarity of HK genes was also highlighted by a significant difference in complexity between HK and tissue-specific gene promoters, as revealed by DNA entropy analysis ([@b38-mmr-16-03-2397]).

While the present study was in progress, an article on the topic was published that suggested that a 'universal' human HK gene does not exist and provided a list of suitable reference genes for individual tissues/organs ([@b11-mmr-16-03-2397]). However, the method employed by that study was different from the approach of the present study in a number of relevant aspects. In particular, the results of the previous study were originally obtained by combining the lists of genes retrieved from studies performed using heterogeneous techniques (such as microarray, EST or RNA-Seq analysis), were analyzed using the logic of classification, previous judgments concerning the suitability of certain genes as HK/reference genes were accepted and then these lists were combined. This approach of combining the lists of results was also used by Chang *et al* ([@b39-mmr-16-03-2397]) and, following ranking, by Shaw *et al* ([@b40-mmr-16-03-2397]). By contrast, the present study re-elaborated and normalized original raw data, and generated a fully quantitative analysis of human gene expression, which may explain certain differences in the results obtained by the algorithm used in the current study. Conversely, certain shared general conclusions were highlighted, including the necessity to calibrate the search criteria for HK genes according to cell/tissue type; however, the general analysis of the present study can still identify certain general-purpose genes with acceptable criteria that may be proposed as reference genes. Several previous studies have demonstrated that the results provided by the TRAM tool were highly reliable, having been confirmed by RT-qPCR experiments for several diverse human tissues, demonstrating a correlation coefficient (r) between TRAM and RT-qPCR data of r=0.98 for brain ([@b34-mmr-16-03-2397]), r=0.99 for hippocampus ([@b41-mmr-16-03-2397]) and r=0.98 for heart ([@b14-mmr-16-03-2397]). However, it is commonly accepted that additional experimental studies may be required to verify that the identified candidate reference gene is suitable for the actual biological condition investigated ([@b42-mmr-16-03-2397]). Additional studies are in progress to verify if the HK profile identified in normal tissues may be applicable to aneuploid cells, in particular for systematic analysis of trisomy 21 cells ([@b43-mmr-16-03-2397]), in light of the fact that all of the best reference genes identified by that study are not located on chromosome 21 and that a very small portion of this chromosome appears to be associated with the basic features of Down syndrome (DS) ([@b44-mmr-16-03-2397]). In this regard, consulting the published differential transcriptome map comparing acute megakaryoblastic leukemia (AMKL) cells from children with DS (DS AMKL) and euploid megakaryocyte cells (euploid MK) ([@b45-mmr-16-03-2397]) reveals promising values for *ACTG1* (DS AMKL/euploid MK gene expression ratio=1.08) and *POM121C* (DS AMKL/euploid MK gene expression ratio=1.01); the ratios range between 0.47 and 3.55 ([@b45-mmr-16-03-2397]) for the other genes listed in [Table III](#tIII-mmr-16-03-2397){ref-type="table"}.

A previous study using RNA-Seq data to identify reference genes across multiple human tissues focused mainly on low SD and so proposed a list of 11 genes with exceptionally low variability ([@b1-mmr-16-03-2397]). The corresponding values have been checked by TRAM analysis in the present study, which confirmed their expression across multiple tissues, with a generally low SD (although not exceptional in the data of the current study). However, these identified genes had low expression values, all in the range of 150--400 in terms of a percentage of the mean value. This was recognized by Kwon *et al* ([@b46-mmr-16-03-2397]), who selected low variability as the leading parameter, as have other studies, whereas the approach of the present study was aimed at finding genes with the best combination of criteria, considering that a high expression value may be advantageous in practice for the usability of a reference gene. Finally, it should be noted that other studies have frequently used very different and original approaches to the problem, using computational classifiers ([@b47-mmr-16-03-2397]), the controlled vocabulary of Medical Subject Headings ([@b48-mmr-16-03-2397]) and Gene Ontology classifications ([@b29-mmr-16-03-2397]).

It may finally be noted that several of the available analysis tools are aimed at determining the best reference genes for normalization of gene expression data, and are largely based on the evaluation of the minimal variation of the expression level of a given gene among different conditions. BestKeeper ([@b49-mmr-16-03-2397]) and GeNorm ([@b50-mmr-16-03-2397]) are commonly used for screening the reference genes to perform an accurate normalization of RT-qPCR data, whereas NormFinder ([@b51-mmr-16-03-2397]) may be used to evaluate reference genes for normalization of RT-qPCR and microarray experiments. Regarding NormFinder, a direct comparison with the tool employed in the present study is not possible, since NormFinder requires the same number of measured values for each gene and the TRAM algorithm does not have this limitation. In addition, NormFinder evaluation is based only on the analysis of variation among different samples, whereas the TRAM approach integrates this parameter with the level of expression (at least medium-high) and with the highest possible number of samples in which each gene is measured; all are essential parameters by which to search for a suitable reference gene, thus allowing the identification of genes with the overall best fit to the three criteria. Finally, although NormFinder has the ability to identify the ideal combination of biologically independent genes for each tissue, this analysis requires the creation of a matrix with two groups of data deriving from two different conditions, which in the case of TRAM can be either one of the ten tissues analyzed or the whole pool. In the whole pool sample, the difference in the number of measures for each gene increases, so the exclusion of a large number of measures to create a matrix of data does not make the direct comparison between NormFinder and TRAM results possible.

In conclusion, the present study provided, to the best of our knowledge, the first systematic analysis to quantitatively combine all of the traditional criteria aimed at identifying the HK genes that are best suited to be reference genes for the study of human gene expression. Several genes were identified and proposed to be suitable in cross-tissue studies, and certain genes were proposed as references for tissue/organ-specific studies. The wealth of data generated by this approach may also provide a representative portrait of typical gene-expression profiles for several human tissues and organs in the form of searchable database tables and suggested that currently uncharacterized transcripts, even EST clusters, may be worthy of further investigation as strong candidates to represent HK genes, or tissue-specific genes, expressed in high levels in human cells.
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###### 

Summary of the samples used in the meta-analysis for 10 specific tissues/organs.

  Sample                                                       ID         n     Data points   Genes    HK^[a](#tfn1-mmr-16-03-2397){ref-type="table-fn"}^   Value   Samples % (n)   SD%
  ------------------------------------------------------------ ---------- ----- ------------- -------- ---------------------------------------------------- ------- --------------- -----
  Whole pool^[b](#tfn2-mmr-16-03-2397){ref-type="table-fn"}^   1--646     646   21,840,330    35,131   27                                                   ≥150    ≥65 (420)       ≤45
  Adipose tissue                                               1--20      20    943,480       25,722   363                                                  ≥300    ≥80 (16)        ≤30
  Bone marrow                                                  46--60     15    548,322       26,097   222                                                  ≥300    ≥80 (12)        ≤30
  Brain                                                        61--84     24    507,799       21,603   174                                                  ≥150    ≥65 (16)        ≤45
  Heart                                                        150--166   17    452,683       34,486   56                                                   ≥150    ≥65 (11)        ≤45
  Kidney                                                       167--183   17    405,285       33,816   65                                                   ≥150    ≥65 (11)        ≤45
  Liver                                                        184--216   33    971,110       35,090   49                                                   ≥150    ≥65 (21)        ≤45
  Lung                                                         217--249   33    817,145       34,872   49                                                   ≥150    ≥65 (21)        ≤45
  Ovary                                                        281--304   24    788,447       34,853   157                                                  ≥150    ≥65 (16)        ≤45
  Skeletal muscle                                              403--418   16    324,382       27,160   77                                                   ≥300    ≥80 (13)        ≤30
  Testis                                                       495--517   23    745,430       34,853   227                                                  ≥150    ≥65 (15)        ≤45

Please refer to the text for a description of the selection criteria used to identify HK genes according to expression values, number of samples and SD.

Whole pool contains all sample data sets related to the 54 different human tissues/organs listed in [Tables I](#tI-mmr-16-03-2397){ref-type="table"} and [II](#tII-mmr-16-03-2397){ref-type="table"}. ID, identifier used in the present study; HK, number of housekeeping genes retrieved; value, expression value; Samples % (n), the percentage of samples in each dataset in which the HK genes fulfiled the selection criteria; n, total sample number; SD%, standard deviation from the mean expression value of a given locus expressed as a percentage.

###### 

Samples used in the meta-analysis for the whole pool in addition to all samples listed in [Table I](#tI-mmr-16-03-2397){ref-type="table"}.

  Sample                ID         n
  --------------------- ---------- ----
  Adrenal gland         21--30     10
  Aorta                 31--34     4
  Appendix              35--38     4
  Bladder               39--41     3
  Blood                 42--45     4
  Breast                85--89     5
  Bronchus              90--95     6
  Ciliary ganglion      96--99     4
  Colon                 100--105   6
  Connective            106        1
  Dental pulp           107--108   2
  Dorsal root ganglia   109--130   22
  Esophagus             131--141   11
  Fallopian tube        142--148   7
  Gall bladder          149        1
  Lymph node            250--266   17
  Mammary gland         267--272   6
  Oral mucosa           273--280   8
  Pancreas              305--315   11
  Parathyroid           316--318   3
  Penis                 319--324   6
  Pericardium           325--326   2
  Pharyngeal mucosa     327--334   8
  Pituitary gland       335--351   17
  Prostate              352--382   31
  Salivary gland        383--402   20
  Skin                  419--431   13
  Small intestine       432--437   6
  Smooth muscle         438--441   4
  Spinal cord           442--465   24
  Spleen                466--483   18
  Stomach               484--488   5
  Synovial membrane     489--494   6
  Thymus                518--532   15
  Thyroid               533--554   22
  Tongue                555--564   10
  Tonsil                565--578   14
  Trachea               579--592   14
  Trigeminal ganglion   593--612   20
  Urethra               613--620   8
  Uterus                621--628   8
  Vagina                629--637   9
  Vena cava             638        1
  Vulva                 639--646   8

ID, identifier used in the present study; n, total sample number.

###### 

A list of the eight genes that best fulfill the criteria proposed for use as a reference in gene expression studies across all 646 pool B samples of human tissues and organs that were examined.

  Mean rank   Gene^[a](#tfn4-mmr-16-03-2397){ref-type="table-fn"}^      Chromosome   Value     n     SD%
  ----------- --------------------------------------------------------- ------------ --------- ----- ------
  2.8         *ACTG1*^[b](#tfn5-mmr-16-03-2397){ref-type="table-fn"}^   17           3,453.7   513   37.8
  5.5         *RPS18*                                                     6          4,933.5   472   41.4
  5.8         *POM121C*                                                   7            349.7   425   28.0
  6.5         *MRPL18*                                                    6            226.6   546   39.4
  6.5         *TOMM5*                                                     9            273.6   426   38.2
  7.0         *YTHDF1*                                                  20             213.0   546   39.1
  7.3         *TPT1*                                                    13           5,941.7   508   43.1
  8.0         *RPS27*                                                     1          4,355.6   513   44.1

Please see [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"} for a complete list of gene definitions.

*ACTG1* was significantly overexpressed in the transcriptome map (q=0.03; where q is the P-value corrected for false discovery rate). Value, expression value; SD%, standard deviation expressed as percentage of the mean expression value for the locus.

###### 

A list of the eight genes that best fulfill the selection criteria proposed for a reference in gene expression studies of human adipose tissue and bone marrow.

  A, Adipose tissue                                                                   
  ------------------- ------------- ----- --------- --------- ----- ---- ----- ------ ------
  25.0                *RPL6*        12    2,207.0   2,069.0   1.1   20   592   11.6   89.5
  27.5                *RPS25*       11    2,189.7   2,113.3   1.0   20   568   14.2   75.2
  27.5                *SOD1*        21    1,273.0   1,231.8   1.0   20   592   12.1   67.9
  33.5                *RNASEK*      17      912.6     881.1   1.0   20   335   11.3   41.7
  35.8                *GABARAP*     17    1,112.7   1,185.6   0.9   20   580   12.7   72.6
  41.3                *ACTG1*       17    3,821.3   3,453.7   1.1   20   513   15.2   37.8
  43.8                *GABARAPL2*   16      591.6     591.9   1.0   20   592   12.7   69.8
  45.0                *MRFAP1*        4   1,583.2   1,499.0   1.1   20   480   17.6   64.2
                                                                                      
  B, Bone marrow                                                                      
                                                                                      
  13.0                *RPL41*       12    5,739.4   5,838.5   1.0   13   568   18.5   45.1
  17.8                *RPLP0*       12    3,659.6   3,341.5   1.1   13   508   16.5   44.5
  17.8                *RPS27*         1   4,494.8   4,355.6   1.0   13   513   19.5   44.1
  23.3                *TUBA1B*      12    2,893.1   2,478.6   1.2   13   508   16.4   81.1
  24.3                *RPSA*          3   2,016.1   2,036.8   1.0   13   575   20.6   80.1
  25.5                *SLC25A3*     12      918.5     956.7   1.0   13   592   17.6   73.5
  26.5                *ACTG1*       17    3,728.3   3,453.7   1.1   13   513   20.3   37.8
  30.0                *EEF1G*       11    2,713.6   2,686.9   1.0   13   587   22.6   48.3

Please see [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"} for a complete list of gene definitions. Value A, mean expression values of the gene in the pool A, including the sample related to the specific tissue; value B, mean expression values of the gene in the whole pool B consisting of all the 646 samples; A/B, ratio between values A and B; SD%, standard deviation expressed as percentage of the mean expression value (A or B) for the locus.

###### 

A list of the eight genes that best fulfill the selection criteria proposed for a reference in gene expression studies of human brain, heart and skeletal muscle.

  A, Brain                                                                             
  -------------------- ------------- ----- --------- --------- ----- ---- ----- ------ -------
  9.3                  *NDUFB4*        3   590.9     545.7     1.1   20   551   20.6   110.0
  9.8                  *NDUFB1*      14    546.7     586.0     0.9   22   592   22.7   59.9
  17.5                 *GSTO1*       10    345.9     370.6     0.9   22   592   22.0   75.5
  28.0                 *AMZ2*        17    299.5     276.1     1.1   20   467   29.3   99.5
  28.8                 *POLR2I*      19    302.8     254.7     1.2   22   568   23.0   79.2
  29.5                 *NDUFA3*      19    365.0     280.9     1.3   20   551   19.7   59.0
  30.0                 *RRAGA*         9   463.0     350.9     1.3   22   592   26.5   45.1
  30.5                 *POMP*        13    283.5     338.2     0.8   20   546   24.0   106.0
                                                                                       
  B, Heart                                                                             
                                                                                       
  10.5                 *MIF*         22    896.7     845.6     1.1   11   527   42.1   66.5
  12.5                 *ECHS1*       10    567.8     571.0     1.0   15   592   43.2   100.3
  13.0                 *FAM96A*      15    338.6     289.7     1.2   11   480   35.0   63.8
  13.5                 *NOP10*       15    474.8     428.5     1.1   13   546   41.4   48.0
  13.5                 *TBCB*        19    319.8     290.6     1.1   15   592   38.8   67.9
  14.8                 *RRAGA*         9   292.4     350.9     0.8   15   592   37.0   45.1
  15.0                 *IFI27*       14    510.4     441.9     1.2   15   592   42.2   103.1
  15.5                 *MB*          22    6,845.8   745.2     9.2   15   592   30.6   260.2
                                                                                       
  C, Skeletal muscle                                                                   
                                                                                       
  4.3                  *RPL41*       12    4,995.8   5,838.5   0.9   16   568   17.3   45.1
  8.3                  *PRDX1*         1   921.2     1,096.5   0.8   16   592   18.5   71.7
  10.8                 *RPL8*        8     2,065.6   2,069.0   1.0   16   513   25.2   44.1
  11.3                 *C14orf166*   14    576.0     505.7     1.1   16   546   19.1   57.0
  11.8                 *JTB*           1   714.0     606.9     1.2   16   592   20.6   61.6
  11.8                 *RPS29*       14    2,751.4   2,551.2   1.1   16   592   25.4   57.9
  13.0                 *SNRPD2*      19    516.4     524.7     1.0   16   592   21.9   57.5
  14.5                 *NOP10*       15    497.5     428.5     1.2   16   546   19.2   48.0

Please see [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"} for a complete list of gene definitions. Value A, mean expression values of the gene in the pool A, including the sample related to the specific tissue; value B, mean expression values of the gene in the whole pool B consisting of all the 646 samples; A/B, ratio between these value A and value B; SD%, standard deviation expressed as percentage of the mean expression value (A or B) for the locus.

###### 

A list of the eight genes that best fulfill the selection criteria proposed for a reference in gene expression studies of human kidney, liver and lung.

  A, Kidney                                                                   
  ----------- ------------- ----- --------- --------- ----- ---- ----- ------ -------
  6.5         *PGAM1*       10    688.8     741.8     0.9   14   556   29.6   64.0
  7.5         *NOP10*       15    413.9     428.5     1.0   12   546   31.9   48.0
  8.0         *FIS1*          7   340.7     329.0     1.0   12   546   29.6   52.9
  9.0         *GPX1*          3   459.9     496.7     0.9   15   592   34.2   66.9
  10.3        *GANAB*       11    266.7     260.0     1.0   15   587   35.1   49.5
  11.0        *NDUFB11*       X   343.8     294.9     1.2   12   551   25.0   67.7
  12.8        *HEBP1*       12    288.6     249.2     1.2   12   551   27.7   53.9
  13.0        *HDGF*          1   444.3     432.2     1.0   14   568   40.5   58.4
                                                                              
  B, Liver                                                                    
                                                                              
  8.5         *HEBP2*         6   335.1     362.5     0.9   31   592   35.8   79.2
  11.8        *NDUFS3*      11    289.3     325.3     0.9   31   592   36.1   60.8
  12.3        *POLR2H*        3   162.0     160.1     1.0   33   641   32.4   45.2
  12.5        *MRPS24*        7   438.5     445.0     1.0   23   426   42.0   57.9
  13.3        *FAM96B*      16    287.1     325.2     0.9   29   546   37.0   47.9
  13.3        *GTF3A*       13    349.5     310.3     1.1   22   501   38.6   62.0
  13.3        *HIST1H2BK*     6   216.3     186.6     1.2   28   568   30.3   72.7
  13.8        *CRELD2*      22    297.3     279.9     1.1   24   467   39.5   52.7
                                                                              
  C, Lung                                                                     
                                                                              
  7.3         *RBX1*        22    283.7     315.4     0.9   29   551   36.6   57.8
  7.5         *RRAGA*         9   289.7     350.9     0.8   31   592   34.9   45.1
  11.5        *LAMTOR5*       1   253.1     344.6     0.7   33   646   34.1   55.7
  11.8        *CNIH1*       14    207.4     250.4     0.8   31   592   32.3   63.4
  12.0        *EPCAM*         2   252.8     256.7     1.0   31   592   39.0   218.7
  12.8        *EIF4A3*      17    271.2     340.0     0.8   25   563   37.8   47.1
  13.5        *ACTG1*       17    3,067.3   3,453.7   0.9   27   513   43.9   37.8
  14.0        *FAM96B*      16    277.0     325.2     0.9   24   546   39.2   47.9

Please see [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"} for a complete list of gene definitions. Value A, mean expression values of the gene in the pool A, including the sample related to the specific tissue; value B, mean expression values of the gene in the whole pool B consisting of all the 646 samples; A/B, ratio between these value A and value B; SD%, standard deviation expressed as percentage of the mean expression value (A or B) for the locus.

###### 

A list of the eight genes that best fulfill the selection criteria proposed for a reference in gene expression studies of human ovary and testis.

  A, Ovary                                                                  
  ----------- ----------- ----- --------- --------- ----- ---- ----- ------ -------
  10.0        *ACTG1*     17    3,547.3   3,453.7   1.0   17   513   30.8   37.8
  20.0        *AP2M1*       3   387.9     375.5     1.0   17   513   32.0   51.8
  22.5        *MIF*       22    885.0     845.6     1.0   17   527   36.5   66.5
  24.3        *NELFCD*    20    240.2     239.5     1.0   17   522   31.3   118.6
  24.5        *RNF181*      2   331.3     356.5     0.9   16   426   24.8   52.5
  28.0        *PSMC1*     14    367.9     421.4     0.9   17   513   29.3   48.8
  30.0        *TMEM147*   19    295.9     282.8     1.0   22   592   35.3   47.2
  30.3        *TERF2IP*   16    323.5     344.6     0.9   22   592   34.7   69.9
                                                                            
  B, Testis                                                                 
                                                                            
  18.5        *TUBA1B*    12    2,774.3   2,478.6   1.1   18   508   30.9   81.1
  21.0        *FAM96B*    16    339.6     325.2     1.0   19   546   28.0   47.9
  22.8        *RPL8*        8   1,637.9   2,069.0   0.8   18   513   27.9   44.1
  23.0        *RPS18*       6   4,434.5   4,933.5   0.9   16   472   34.9   41.4
  24.5        *ACTG1*     17    4,320.0   3,453.7   1.3   18   513   27.7   37.8
  29.3        *RPS27*       1   5,444.6   4,355.6   1.3   18   513   32.5   44.1
  31.5        *TBCB*      19    343.1     290.6     1.2   21   592   29.1   67.9
  32.3        *RPL41*     12    4,676.1   5,838.5   0.8   20   568   36.1   45.1

Please see [Table VIII](#tVIII-mmr-16-03-2397){ref-type="table"} for a complete list of gene definitions. Value A, mean expression values of the gene in the pool A, including the sample related to the specific tissue; value B, mean expression values of the gene in the whole pool B consisting of all the 646 samples; A/B, ratio between these value A and value B; SD%, standard deviation expressed as percentage of the mean expression value (A or B) for the locus.

###### 

Gene symbols, corresponding descriptions and the number of recurrences (n) in the Tables for the genes listed in [Tables III](#tIII-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}.

  Gene symbol    n       Gene description
  -------------- ------- ------------------------------------------------------------------------------
  ***ACTG1***    5       **Actin γ 1**
  *AMZ2*         1       Archaelysin family metallopeptidase 2
  *AP2M1*        1       Adaptor-related protein complex 2, µ1 subunit
  *C14orf166*    1       Chromosome 14 open reading frame 166
  *CNIH1*        1       Cornichon family AMPA receptor auxiliary protein 1
  *CRELD2*       1       Cysteine rich with EGF like domains 2
  *ECHS1*        1       Enoyl-CoA hydratase, short chain 1
  *EEF1G*        1       Eukaryotic translation elongation factor 1γ
  *EIF4A3*       1       Eukaryotic translation initiation factor 4A3
  *EPCAM*        1       Epithelial cell adhesion molecule
  *FAM96A*       1       Family with sequence similarity 96 member A
  ***FAM96B***   **3**   **Family with sequence similarity 96 member B**
  *FIS1*         1       Fission, mitochondrial 1
  *GABARAP*      1       GABA type A receptor-associated protein
  *GABARAPL2*    1       GABA type A receptor associated protein like 2
  *GANAB*        1       Glucosidase II α subunit
  *GPX1*         1       Glutathione peroxidase 1
  *GSTO1*        1       Glutathione S-transferase ω1
  *GTF3A*        1       General transcription factor IIIA
  *HDGF*         1       Heparin binding growth factor
  *HEBP1*        1       Heme binding protein 1
  *HEBP2*        1       Heme binding protein 2
  *HIST1H2BK*    1       Histone cluster 1 H2B family member k
  *IFI27*        1       Interferon α-inducible protein 27
  *JTB*          1       Jumping translocation breakpoint
  *LAMTOR5*      1       Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
  *MB*           1       Myoglobin
  ***MIF***      **2**   **Macrophage migration inhibitory factor (glycosylation-inhibiting factor)**
  *MRFAP1*       1       Morf4 family associated protein 1
  *MRPL18*       1       Mitochondrial ribosomal protein L18
  *MRPS24*       1       Mitochondrial ribosomal protein S24
  *NDUFA3*       1       NADH:ubiquinone oxidoreductase subunit A3
  *NDUFB1*       1       NADH:ubiquinone oxidoreductase subunit B1
  *NDUFB4*       1       NADH:ubiquinone oxidoreductase subunit B4
  *NDUFB11*      1       NADH:ubiquinone oxidoreductase subunit B11
  *NDUFS3*       1       NADH:ubiquinone oxidoreductase core subunit S3
  *NELFCD*       1       Negative elongation factor complex member C/D
  ***NOP10***    **3**   **NOP10 ribonucleoprotein**
  *PGAM1*        1       Phosphoglycerate mutase 1
  *POLR2H*       1       RNA polymerase II subunit H
  *POLR2I*       1       RNA polymerase II subunit I
  *POM121C*      1       POM121 transmembrane nucleoporin C
  *POMP*         1       Proteasome maturation protein
  *PRDX1*        1       Peroxiredoxin 1
  *PSMC1*        1       Proteasome 26S subunit, ATPase 1
  *RBX1*         1       Ring-box 1
  *RNASEK*       1       Ribonuclease K
  *RNF181*       1       Ring finger protein 181
  *RPL6*         1       Ribosomal protein L6
  ***RPL8***     **2**   **Ribosomal protein L8**
  ***RPL41***    **3**   **Ribosomal protein L41**
  *RPLP0*        1       Ribosomal protein lateral stalk subunit P0
  ***RPS18***    **2**   **Ribosomal protein S18**
  *RPS25*        1       Ribosomal protein S25
  ***RPS27***    **3**   **Ribosomal protein S27**
  *RPS29*        1       Ribosomal protein S29
  *RPSA*         1       Ribosomal protein SA
  ***RRAGA***    **3**   **Ras related GTP binding A**
  *SLC25A3*      1       Solute carrier family 25 member 3
  *SNRPD2*       1       Small nuclear ribonucleoprotein D2 polypeptide
  *SOD1*         1       Superoxide dismutase 1
  ***TBCB***     **2**   **Tubulin folding cofactor B**
  *TERF2IP*      1       TERF2 interacting protein
  *TMEM147*      1       Transmembrane protein 147
  *TOMM5*        1       Translocase of outer mitochondrial membrane 5
  *TPT1*         1       Tumor protein, translationally-controlled 1
  ***TUBA1B***   **2**   **Tubulin α1b**
  *YTHDF1*       1       YTH N6-methyladenosine RNA binding protein 1

The genes with a number of recurrences (n) \>1 are shown in bold. AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CoA, coenzyme A; EGF, epidermal growth factor; GTP, guanosine 5′-triphosphate; MAPK, mitogen-activated protein kinase; Morf4, mortality factor 4 (pseudogene); MTOR, mechanistic target of rapamycin; TERF2, telomeric repeat binding factor 2.

###### 

A list of all 63 genes identified for the 10 specific tissues and organs presented in [Tables IV](#tIV-mmr-16-03-2397){ref-type="table"}--[VII](#tVII-mmr-16-03-2397){ref-type="table"}.

  Number   Gene
  -------- -------------
    1      *ACTG1*
    2      *AMZ2*
    3      *AP2M1*
    4      *C14orf166*
    5      *CNIH1*
    6      *CRELD2*
    7      *ECHS1*
    8      *EEF1G*
    9      *EIF4A3*
  10       *EPCAM*
  11       *FAM96A*
  12       *FAM96B*
  13       *FIS1*
  14       *GABARAP*
  15       *GABARAPL2*
  16       *GANAB*
  17       *GPX1*
  18       *GSTO1*
  19       *GTF3A*
  20       *HDGF*
  21       *HEBP1*
  22       *HEBP2*
  23       *HIST1H2BK*
  24       *IFI27*
  25       *JTB*
  26       *LAMTOR5*
  27       *MB*
  28       *MIF*
  29       *MRFAP1*
  30       *MRPS24*
  31       *NDUFA3*
  32       *NDUFB1*
  33       *NDUFB11*
  34       *NDUFB4*
  35       *NDUFS3*
  36       *NELFCD*
  37       *NOP10*
  38       *PGAM1*
  39       *POLR2H*
  40       *POLR2I*
  41       *POMP*
  42       *PRDX1*
  43       *PSMC1*
  44       *RBX1*
  45       *RNASEK*
  46       *RNF181*
  47       *RPL41*
  48       *RPL6*
  49       *RPL8*
  50       *RPLP0*
  51       *RPS18*
  52       *RPS25*
  53       *RPS27*
  54       *RPS29*
  55       *RPSA*
  56       *RRAGA*
  57       *SLC25A3*
  58       *SNRPD2*
  59       *SOD1*
  60       *TBCB*
  61       *TERF2IP*
  62       *TMEM147*
  63       *TUBA1B*
